Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2013 Dec;36(12):4030-5.
doi: 10.2337/dc13-1074. Epub 2013 Oct 15.

Effectiveness of Early Intensive Therapy on β-Cell Preservation in Type 1 Diabetes

Collaborators, Affiliations
Free PMC article
Randomized Controlled Trial

Effectiveness of Early Intensive Therapy on β-Cell Preservation in Type 1 Diabetes

Bruce Buckingham et al. Diabetes Care. .
Free PMC article

Abstract

Objective: To assess effectiveness of inpatient hybrid closed-loop control (HCLC) followed by outpatient sensor-augmented pump (SAP) therapy initiated within 7 days of diagnosis of type 1 diabetes on the preservation of β-cell function at 1 year.

Research design and methods: Sixty-eight individuals (mean age 13.3 ± 5.7 years; 35% female, 92% Caucasian) were randomized to HCLC followed by SAP therapy (intensive group; N = 48) or to the usual-care group treated with multiple daily injections or insulin pump therapy (N = 20). Primary outcome was C-peptide concentrations during mixed-meal tolerance tests at 12 months.

Results: Intensive-group participants initiated HCLC a median of 6 days after diagnosis for a median duration of 71.3 h, during which median participant mean glucose concentration was 140 mg/dL (interquartile range 134-153 mg/dL). During outpatient SAP, continuous glucose monitor (CGM) use decreased over time, and at 12 months, only 33% of intensive participants averaged sensor use ≥6 days/week. In the usual-care group, insulin pump and CGM use were initiated prior to 12 months by 15 and 5 participants, respectively. Mean HbA1c levels were similar in both groups throughout the study. At 12 months, the geometric mean (95% CI) of C-peptide area under the curve was 0.43 (0.34-0.52) pmol/mL in the intensive group and 0.52 (0.32-0.75) pmol/mL in the usual-care group (P = 0.49). Thirty-seven (79%) intensive and 16 (80%) usual-care participants had a peak C-peptide concentration ≥0.2 pmol/mL (P = 0.30).

Conclusions: In new-onset type 1 diabetes, HCLC followed by SAP therapy did not provide benefit in preserving β-cell function compared with current standards of care.

Trial registration: ClinicalTrials.gov NCT00760526.

Figures

Figure 1
Figure 1
Box plots for 2-h stimulated C-peptide AUC at each follow-up visit. The bottom and top of each box denote the 25th and 75th percentiles, respectively; the line inside the box denotes the median, and the dot is the geometric mean. The vertical axis is on a log(x + 1) scale.
Figure 2
Figure 2
HbA1c results. The bottom and top of each box denote the 25th and 75th percentiles, respectively; the line inside the box denotes the median, and the dot is the mean. The 6-week value is a local HbA1c measurement; others are from the central laboratory.
Figure 3
Figure 3
Insulin doses at each follow-up visit. The bottom and top of each box denote the 25th and 75th percentiles, respectively; the line inside the box denotes the median, and the dot is the mean.

Similar articles

See all similar articles

Cited by 15 articles

See all "Cited by" articles

References

    1. Steffes MW, Sibley S, Jackson M, Thomas W. β-cell function and the development of diabetes-related complications in the diabetes control and complications trial. Diabetes Care 2003;26:832–836 - PubMed
    1. The Diabetes Control and Complications Trial Research Group Effect of intensive therapy on residual β-cell function in patients with type 1 diabetes in the diabetes control and complications trial. A randomized, controlled trial. Ann Intern Med 1998;128:517–523 - PubMed
    1. Mirouze J, Selam JL, Pham TC, Mendoza E, Orsetti A. Sustained insulin-induced remissions of juvenile diabetes by means of an external artificial pancreas. Diabetologia 1978;14:223–227 - PubMed
    1. Like A. Insulin injections prevent diabetes (DB) in biobreeding/worcester (BB/Wor) rats. Diabetes 1986;35:74A. - PubMed
    1. Appel MC, O'Neil JJ. Prevention of spontaneous diabetes in the bb/w rat by insulin treatment. Pancreas 1986;1:356–368 - PubMed

Publication types

MeSH terms

Associated data

Feedback